{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:05:32Z","timestamp":1794956732310,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ygyno.2006.02.038","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T12:05:47Z","timestamp":1145534747000},"page":"103-110","source":"Crossref","is-referenced-by-count":42,"title":["What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence"],"prefix":"10.1016","volume":"102","author":[{"given":"Katy","family":"Foulmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Guastalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Caminet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Trillet-Lenoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Raudrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Golfier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.02.038_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","article-title":"Epidemiology and aetiology of gestational trophoblastic diseases","volume":"4","author":"Altieri","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3181\/00379727-93-22757","article-title":"Effects of methotrexate therapy upon choriocarcinomas and chorioadenomas","author":"Li","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ygyno.2006.02.038_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9378(61)90283-6","article-title":"Five years experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women","volume":"82","author":"Hertz","year":"1961","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E","article-title":"Risk and prognostic factors in trophoblastic neoplasia","volume":"38","author":"Bagshawe","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.02.038_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-0528.1964.tb04320.x","article-title":"Infusion therapy for pelvic trophoblastic tumors","volume":"71","author":"Bagshawe","year":"1964","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"key":"10.1016\/j.ygyno.2006.02.038_bib6","first-page":"1015","article-title":"Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women","volume":"22","author":"Ross","year":"1962","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.02.038_bib7","first-page":"341","article-title":"Actinomycin D as initial therapy of trophoblastic disease","volume":"39","author":"Goldstein","year":"1972","journal-title":"Obstret. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2006.02.038_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9378(84)80112-X","article-title":"Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms","volume":"1 150","author":"Sung","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib9","first-page":"49","article-title":"Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use","volume":"36","author":"Kohorn","year":"1991","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2006.02.038_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/gyno.1994.1169","article-title":"5-Day methotrexate for women with metastatic gestational trophoblastic disease","volume":"54","author":"Soper","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib11","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0002-9378(87)80285-5","article-title":"Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate","volume":"157","author":"Barter","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2006.02.038_bib12","first-page":"413","article-title":"Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease","volume":"72","author":"Homesley","year":"1988","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/gyno.1996.0041","article-title":"A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease","volume":"60","author":"Hoffman","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib14","first-page":"434","article-title":"Society of obstetricians and gynaecologists of Canada; Gynaecologic Oncologists of Canada; Society of Canadian Colposcopists. Gestational trophoblastic disease","volume":"24","author":"Gerulath","year":"2002","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ygyno.2006.02.038_bib15","unstructured":"World Health Organization Scientific Group: Gestational trophoblastic disease. In Technical Report Series 692. Geneva: World Health Organization; 1983."},{"key":"10.1016\/j.ygyno.2006.02.038_bib16","unstructured":"International Federation of Gynecology and Obstetrics: Annual report on the results of treatment in Gynecological Cancer, 22nd ed. Stockholm: FIGO; 1994."},{"issue":"1","key":"10.1016\/j.ygyno.2006.02.038_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","article-title":"The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment","volume":"11","author":"Kohorn","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2006.02.038_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1525-1438.2000.010004318.x","article-title":"A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease","volume":"10","author":"Hancock","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.02.038_bib19","first-page":"538","article-title":"A plea for the creation of trophoblastic disease reference centers in France","volume":"29","author":"Golfier","year":"2000","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"key":"10.1016\/j.ygyno.2006.02.038_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1989.tb03318.x","article-title":"The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)","volume":"96","author":"Bagshawe","year":"1989","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"20","key":"10.1016\/j.ygyno.2006.02.038_bib21","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"1","author":"McNeish","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(95)90575-8","article-title":"Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumours","volume":"172","author":"Lurain","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0090-8258(86)90123-X","article-title":"Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease","volume":"23","author":"Berkowitz","year":"1986","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib24","first-page":"355","article-title":"Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience","volume":"47","author":"Garrett","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2006.02.038_bib25","first-page":"93","article-title":"Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms","volume":"51","author":"Goldstein","year":"1978","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib26","first-page":"213","article-title":"Management of low-risk metastatic gestational trophoblastic disease","volume":"26","author":"Jones","year":"1981","journal-title":"J. Reprod. Med."},{"issue":"144","key":"10.1016\/j.ygyno.2006.02.038_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0002-9378(82)90400-8","article-title":"Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid","volume":"1","author":"Smith","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"152","key":"10.1016\/j.ygyno.2006.02.038_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9378(85)80178-2","article-title":"Methotrexate with citrovorum factor rescue in gestational trophoblastic disease","volume":"1","author":"Wong","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib29","first-page":"653","article-title":"Current management of low-risk metastatic gestational trophoblastic disease","volume":"32","author":"Jones","year":"1987","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2006.02.038_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0090-8258(90)90108-W","article-title":"Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors","volume":"36","author":"Berkowitz","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0090-8258(90)90257-L","article-title":"Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study","volume":"39","author":"Homesley","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/gyno.1994.1211","article-title":"High-dose methotrexate for gestational trophoblastic disease","volume":"54","author":"Elit","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.02.038_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1067\/mob.2000.108077","article-title":"Methotrexate infusion in low-risk gestational trophoblastic disease","volume":"183","author":"Wong","year":"2000","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806002150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806002150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T01:55:18Z","timestamp":1547690118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806002150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0090825806002150"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.02.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}